Coronavirus Essential | India's Covaxin may enter phase 3 trials in October; Bharat Biotech to make billion doses of intranasal vaccines

Episode 2908  ·  Sep 24, 2020, 01:03 PM
Headliner
Share
Subscribe
Tune in to the Coronavirus Essential podcast with Sakshi Batra for all the news on the pandemic.
Share
Subscribe
Next
Hot Stocks | Apollo Hospitals, Wipro, Granules India three buy calls for short term
Top episodes
The Market Podcast | Why Airtel rose despite AGR setback and what to do with DMart, Yes Bank and IRCTC
by Moneycontrol Podcast
Interview | Ramesh Damani's thumb rule of 24% returns can make you really rich
by Moneycontrol Podcast
Coronavirus Essential | PM Modi’s lights out, light up message; lockdown may continue until September, says study
by Moneycontrol Podcast